RxDoctor Payments Data

Valerie Gorman, MD

Surgery · Waxahachie, TXNPI 1376576017

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $209,096 of the $242,772 with a category attached, or 86.1%. Hologic Inc accounts for 83.5% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $62,989 and has fallen 63.1% since, to $23,215 in 2025. Among surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$242,772in general payments, 2019–2025

Across 216 payments — averaging $1123.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Hologic Inc$203K
  • Focal Therapeutics, Inc.$25K
  • Bioptics, Inc.$4K
  • GE HealthCare$3K
  • Myriad Genetic Laboratories, Inc.$3K
  • Stryker$2K
  • plus $2K from 13 others

What the payments were for

  • Consulting fees$209,09686%
  • Speaking & faculty fees$9,3384%
  • Travel & lodging$17,4107%
  • Food & beverage$6,4293%
  • Education$5000%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$242,772 in reported general payments places this provider in the 95th percentile of 1,830 surgery providers in Texas.

See all surgery providers in Texas

Medicare billing

Part B allowed, 2024
$71,526
Medicare patients
155
Services billed
379

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clindamycin Hcl12$107
Tramadol Hcl35$98

Paid to pharmacies, not to this prescriber.

Other surgery in Waxahachie

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →